此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparative Effects of Mirror Therapy, Proprioceptive Neuromuscular Facilitation, and Constraint-Induced Movement Therapy on Upper Limb Motor Recovery in Stroke Survivors: A Three-Arm Randomized Controlled Trial

This study aimed to compare the effects of these three interventions on upper limb motor recovery in stroke survivors.

A three-arm randomized controlled trial was conducted in which eligible participants (N=90) with post-stroke upper limb hemiparesis were randomly allocated into three groups of 30 each: MT group, PNF group, and CIMT group. All groups received their respective interventions alongside conventional physiotherapy, five sessions per week for six weeks.

研究概览

详细说明

Stroke remains a leading cause of long-term disability worldwide, with upper limb motor impairment being one of the most prevalent and debilitating consequences. While several neurorehabilitation approaches have demonstrated efficacy individually, limited evidence existed comparing the relative effectiveness of mirror therapy (MT), proprioceptive neuromuscular facilitation (PNF), and constraint-induced movement therapy (CIMT) within a single trial framework. This study aimed to compare the effects of these three interventions on upper limb motor recovery in stroke survivors.

A three-arm randomized controlled trial was conducted in which eligible participants (N=90) with post-stroke upper limb hemiparesis were randomly allocated into three groups of 30 each: MT group, PNF group, and CIMT group. All groups received their respective interventions alongside conventional physiotherapy, five sessions per week for six weeks. The outcome measure were the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Action Research Arm Test (ARAT), Modified Ashworth Scale (MAS) and grip strength via hand-held dynamometry. Assessments were performed at baseline and at after 12 weeks post-intervention.

研究类型

介入性

注册 (实际的)

90

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Punjab Province
      • Gujrat、Punjab Province、巴基斯坦
        • Ikram Hospital, Gujrat

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

Stroke Patients Both male and female Age: 25-65 years -

Exclusion Criteria:

unable to perform exercises Do not provide consent Cognitive Impairment

-

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:镜子疗法
Mirror Therapy: Participant in the group were provided mirror therapy for a duration of 12 weeks
有源比较器:Proprioceptive Neuromuscular Facilitation
PNF Group: Participant were given PNF therapy for a total duration of 12 weeks
有源比较器:Constraint-Induced Movement Therapy
Constraint-induced movement therapy: Participant were given Constraint-induced movement therapy for a total duration of 12 weeks

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Action Research Arm Test
大体时间:12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks
Fugl-Meyer Assessment for Upper Extremity
大体时间:12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks
Modified Ashworth Scale
大体时间:12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks
grip strength via hand-held dynamometry
大体时间:12 weeks
The assessment were taken at baseline and after 12 weeks of intervention
12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年7月3日

初级完成 (实际的)

2026年1月3日

研究完成 (实际的)

2026年1月3日

研究注册日期

首次提交

2026年6月27日

首先提交符合 QC 标准的

2026年6月27日

首次发布 (实际的)

2026年7月6日

研究记录更新

最后更新发布 (实际的)

2026年7月6日

上次提交的符合 QC 标准的更新

2026年6月27日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅